{"id":36864,"date":"2020-09-10T09:00:00","date_gmt":"2020-09-10T07:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&p=36864"},"modified":"2023-09-06T16:49:13","modified_gmt":"2023-09-06T14:49:13","slug":"ipsen-va-presenter-de-nouvelles-donnees-lors-de-la-reunion-annuelle-de-lasbmr-sur-le-traitement-potentiel-de-la-fibrodysplasie-ossifiante-progressive-fop-comprenant-les-resultats-de-l","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-va-presenter-de-nouvelles-donnees-lors-de-la-reunion-annuelle-de-lasbmr-sur-le-traitement-potentiel-de-la-fibrodysplasie-ossifiante-progressive-fop-comprenant-les-resultats-de-l\/","title":{"rendered":"Ipsen va pr\u00e9senter de nouvelles donn\u00e9es lors de la r\u00e9union annuelle de l\u2019ASBMR sur le traitement potentiel de la fibrodysplasie ossifiante progressive (FOP), comprenant les r\u00e9sultats de l\u2019\u00e9tude internationale de Phase III MOVE"},"content":{"rendered":"